Nasal fentanyl alone plus buccal midazolam: an open-label, randomised, controlled feasibility study in the dying | BMJ Supportive & Palliative Care

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

Short report

Nasal fentanyl alone plus buccal midazolam: an open-label, randomised, controlled feasibility study in the dying

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Perkins P, Parkinson A, Akyea RK, et al

Nasal fentanyl alone plus buccal midazolam: an open-label, randomised, controlled feasibility study in the dying

BMJ Supportive & Palliative Care 2020;10:300-303.